Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) Short Interest Up 25.8% in April

Acura Pharmaceuticals, Inc. (OTCMKTS:ACURGet Rating) was the target of a large growth in short interest in April. As of April 30th, there was short interest totalling 30,700 shares, a growth of 25.8% from the April 15th total of 24,400 shares. Based on an average trading volume of 8,100 shares, the short-interest ratio is currently 3.8 days.

Shares of OTCMKTS:ACUR opened at $0.40 on Tuesday. The company has a market cap of $26.16 million, a price-to-earnings ratio of -13.33 and a beta of 0.42. The company has a debt-to-equity ratio of 1.97, a current ratio of 0.86 and a quick ratio of 0.86. The firm has a 50 day simple moving average of $0.45 and a 200 day simple moving average of $0.49. Acura Pharmaceuticals has a one year low of $0.29 and a one year high of $0.75.

About Acura Pharmaceuticals (Get Rating)

Acura Pharmaceuticals, Inc, an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products.

Recommended Stories

Receive News & Ratings for Acura Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acura Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.